What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?

por Akilov, Oleg E.
Publicado 2023

Hydroxychloroquine for the treatment of hidradenitis suppurativa

por Brant, Elena Gonzalez, Akilov, Oleg
Publicado 2023

Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma

por Xiao, Amy, Akilov, Oleg E.
Publicado 2022

Romidepsin Controls Chronic Lymphocytic Leukemia in a Patient with Mycosis Fungoides

por Lemchak, David. M., Akilov, Oleg. E.
Publicado 2016

Pseudolymphoma of the nipple treated with topical imiquimod and cryotherapy

por Xiao, Amy, Miedler, John D., Akilov, Oleg E.
Publicado 2022

CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule

por Xiao, Amy, Beatty, Colleen J., Choudhary, Sonal, Akilov, Oleg E.
Publicado 2023

CD56(−) extranodal natural killer (NK)/T-cell lymphoma, nasal type presenting as skin ulcers in a white man

por Vainder, Charles, Ho, Jonhan, Swerdlow, Steven H., Akilov, Oleg E.
Publicado 2016

Effective treatment of mogamulizumab-induced head and neck dermatitis with fluconazole in a patient with peripheral T-Cell lymphoma

por Asokan, Ishan, Singh, Sanminder, Moesch, John, Ho, Jonhan, Akilov, Oleg E.
Publicado 2021

Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma

por Dulmage, Brittany O., Akilov, Oleg, Vu, John R., Falo, Louis D., Geskin, Larisa J.
Publicado 2019

The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma

por Kim, Ellen J., Guitart, Joan, Querfeld, Christiane, Girardi, Michael, Musiek, Amy, Akilov, Oleg E., Angello, James T., Bailey, William L., Geskin, Larisa J.
Publicado 2021

Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4(+) BTLA(+) T Cells in Tumor Microenvironment of Mycosis Fungoides

por Jiang, Tony T., Kruglov, Oleg, Lin, Gloria H. Y., Minic, Angela, Jordan, Kimberly, Uger, Robert A., Wong, Mark, Shou, Yaping, Akilov, Oleg E.
Publicado 2021

Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma

por Gill, Raman Preet Kaur, Gantchev, Jennifer, Martínez Villarreal, Amelia, Ramchatesingh, Brandon, Netchiporouk, Elena, Akilov, Oleg E., Ødum, Niels, Gniadecki, Robert, Koralov, Sergei B., Litvinov, Ivan V.
Publicado 2022

International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19

por Geskin, Larisa J, Garcia-Saleem, Tiffany, Akilov, Oleg E, Enz, Paula, Guenova, Emmanuella, Ortiz-Romero, Pablo L, Papadavid, Evangelia, Quaglino, Pietro, Rozati, Sima, Stonesifer, Connor, Burns, Austin, Khaleel, Alexandra, Scarisbrick, Julia J
Publicado 2021

The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-life Clinical Data

por AMITAY-LAISH, Iris, GUENOVA, Emmanuella, ORTIZ-ROMERO, Pablo L., VICO-ALONSO, Cristina, ROZATI, Sima, GESKIN, Larisa J., NIKOLAOU, Vasiliki, PAPADAVID, Evangelia, BARZILAI, Aviv, PAVLOVSKY, Lev, DIDKOVSKY, Elena, NAVEH, Hadas PRAG, AKILOV, Oleg E., HODAK, Emmilia
Publicado 2020

United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic

por Zic, John A., Ai, Weiyun, Akilov, Oleg E., Carter, Joi B., Duvic, Madeleine, Foss, Francine, Girardi, Michael, Gru, Alejandro A., Kim, Ellen, Musiek, Amy, Olsen, Elise A., Schieke, Stefan M., Shinohara, Michi, Zain, Jasmine M., Geskin, Larisa J.
Publicado 2020

International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study

por Geskin, Larisa J., Kwinta, Bradley D., Garcia-Saleem, Tiffany J., Akilov, Oleg E., Enz, Paula A., Guenova, Emmanuella, Ortiz-Romero, Pablo L., Papadavid, Evangelia, Quaglino, Pietro, Rozati, Sima, Stonesifer, Connor J., Burns, Austin, Stringer, William S., Tarin, Eloy, Scarisbrick, Julia J.
Publicado 2023

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data

por Horwitz, Steven M., Scarisbrick, Julia J., Dummer, Reinhard, Whittaker, Sean, Duvic, Madeleine, Kim, Youn H., Quaglino, Pietro, Zinzani, Pier Luigi, Bechter, Oliver, Eradat, Herbert, Pinter-Brown, Lauren, Akilov, Oleg E., Geskin, Larisa, Sanches, Jose A., Ortiz-Romero, Pablo L., Weichenthal, Michael, Fisher, David C., Walewski, Jan, Trotman, Judith, Taylor, Kerry, Dalle, Stephane, Stadler, Rudolf, Lisano, Julie, Bunn, Veronica, Little, Meredith, Prince, H. Miles
Publicado 2021

Response to brentuximab vedotin versus physician’s choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis

por Kim, Youn H., Prince, H. Miles, Whittaker, Sean, Horwitz, Steven M., Duvic, Madeleine, Bechter, Oliver, Sanches, Jose A., Stadler, Rudolf, Scarisbrick, Julia, Quaglino, Pietro, Zinzani, Pier Luigi, Wolter, Pascal, Eradat, Herbert, Pinter-Brown, Lauren C., Ortiz-Romero, Pablo L., Akilov, Oleg E., Trotman, Judith, Taylor, Kerry, Weichenthal, Michael, Walewski, Jan, Fisher, David, McNeeley, Marise, Gru, Alejandro A., Brown, Lisa, Palanca-Wessels, M. Corinna, Lisano, Julie, Onsum, Matthew, Bunn, Veronica, Little, Meredith, Trepicchio, William L., Dummer, Reinhard
Publicado 2021